TrialRMD open2025

Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies.

Laura C Coates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.